Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HTA: why it matters in the changing balance of purchasing power

This article was originally published in Clinica

Executive Summary

As purchasing decision-making shifts increasingly from clinicians to purchasing administrators equipped with a growing array of tools to measure the effectiveness of medical devices, how should manufacturers respond? Consultant Mark Charny* examines the implications of the changing dynamics and suggests how companies can best position themselves to manage the tricky business of being able to make clinical and non-clinical decision-makers receptive to their products





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts